Get notified when TELO files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsRed Flags Detected
- Departure Of Cfo (new) — The Chief Financial Officer departed the company effective June 6, 2026.
Telomir Pharmaceuticals CFO departs, replaced by fractional consultant at $6K/month
Filed June 8, 2026 · Period ending June 3, 2026 · ~1 min read
Key Changes
-
medium
CFO Alan Weichselbaum departed effective June 6, 2026. Company states departure was not due to any disagreement on operations, policies, or practices.
Item 5.02 verify on EDGAR → -
medium
Andriy Mushak appointed fractional CFO at $6,000/month through consulting firm LMAM, rather than as full-time employee. Mushak is a CPA with 20+ years SEC reporting experience.
Item 5.02 verify on EDGAR → -
medium
Fractional CFO structure may signal cost management or transitional arrangement rather than permanent executive hire.
Item 5.02 verify on EDGAR →
This preview is just the start — the full report includes the narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.
Want to see a complete report first? Today's free report (THRM 10-Q) is open in full — no account needed.
Partner
Trade TELO commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Thanks — your feedback helps us improve report quality.
Source-verified from EDGAR · Narrative written by AI · Jun 9, 2026 · How we verify